Downside of One-Size-Fits-All: Rethinking Weight-Loss Medications Strategy
A comprehensive approach to obesity management goes beyond prescribing medications for a quick fix.
A comprehensive approach to obesity management goes beyond prescribing medications for a quick fix.
At HLTH 2023, I had dozens of conversations with providers, digital health investors, startup CEOs and other players in the healthcare industry. When I got home, I compiled seven refreshingly honest takes I heard from them while at the conference.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Providence announced that it will spin out its fourth digital health startup in the first quarter of next year. The company, called Praia Health, offers a platform designed to build stronger relationships with patients by personalizing their healthcare journeys and connecting them to relevant resources and services.
While the average lifespan for Americans is 77.9 years, Americans are living only 65.9 years in good health. A new Deloitte report shows that if changes are made, Americans’ average lifespan could reach 90 years by 2040, with 85 of those years being in good health.
Health technologies are often built based on the "reference man" and frequently don't take other demographics into account. It shouldn't be this way, experts argued on a panel Thursday at the HIMSS 2023 conference.
Intermountain Healthcare recently partnered with Story Health to help manage patients’ heart failure by increasing access to specialty care. Under the partnership, Intermountain clinicians are working with Story’s health coaches to help patients keep up with their treatment plans while they’re outside the walls of the doctor’s office.
The company touts its personalized approach to helping patients who need the most support with medications, like those who are managing multiple health conditions.
The care plans, available through the company's app, draw on predictive technology to help identify preventive treatments for lower-risk and higher-risk patients alike. Patients are reminded to schedule follow-up appointments, screenings and annual wellness visits, along with adhering to treatment recommendations.
The U.S. Food and Drug Administration switched perspectives concerning patient-centric medicine on Feb. 19 when it approved the marketing of genetics testing company 23andMe’s carrier test for Bloom Syndrome – bringing it back to life after previous ethical/technical issues. Generally speaking, this was great news and demonstrates the FDA’s willingness to adapt, but there are still […]